Allison Inserro

Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.

She has an MPA from New York University. You can connect with Allison on LinkedIn.

Articles by Allison Inserro

In a closely watched case testing an idea pushed by the Trump administration, a federal judge Friday blocked Kentucky’s Medicaid waiver, which required many beneficiaries to work, volunteer, or train for a job as a condition of coverage. Judge James E. Boasberg of Federal District Court for the District of Columbia ruled that CMS' approval of the plan had been “arbitrary and capricious.”

CMS is launching a demonstration of its Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI), which pushes Medicare Advantage (MA) providers into taking on more risk. The demonstration, which has to be approved and adopted, would waive Merit-based Incentive Payment System (MIPS) requirements for doctors opting into the new program.

Payers have been rolling out disease management programs as a way to both control costs and improve outcomes for patients with chronic diseases, such as chronic obstructive pulmonary disease, asthma, diabetes, and others. But what happens to health outcomes when components of care considered COPD disease management in the United States are considered part of usual care elsewhere in the world?

Oklahoma’s Medicaid program is the first to win approval from CMS to negotiate supplemental rebate agreements involving value-based purchasing (VBP) arrangements with drug manufacturers, with the aim of producing extra rebates for the state if clinical outcomes are not reached. Separately, CMS denied an application from Massachusetts requesting the ability to exclude certain Medicaid-covered outpatient drugs through a closed formulary.

The United States Preventive Services Task Force (USPSTF) updated its 2011 recommendation about osteoporosis screening, recommending that women over the age of 65 years continue to get screened and issuing new information about how clinicians should use screening tools to evaluate women younger than 65 years at high risk for developing the bone disease.

CMS Administrator Seema Verma said the agency is seeking public comment on the so-called Stark Law, which was enacted to prevent independent physicians from referring Medicare patients to facilities where they have a financial benefit. The agency said it was focusing, among other things, on how the law may impede care coordination.

The Justice Department said that Healogics, a Florida-based wound care chain, agreed to pay up to $22.51 million to settle allegations that it violated the False Claims Act by knowingly causing wound care centers to bill Medicare for medically unnecessary and unreasonable hyperbaric oxygen (HBO) therapy.

Health insurer Humana and pharmacy chain Walgreens announced Tuesday they are opening joint primary care clinics for senior citizens in Kansas City, Missouri. Separately, a report from America’s Health Insurance Plans (AHIP) found that Medicare Advantage populations continue to be more diverse and represent a larger share of low-income seniors than traditional fee-for-service (FFS) Medicare beneficiaries.

Even though patients with advanced chronic obstructive pulmonary disease (COPD) can suffer from the same distressing symptoms as those with end-stage cancer, they are less likely to receive palliative care than those with other terminal illnesses, a recent study found.

For true comprehensive community wellness to take place, barriers must end between the old silos of what is considered “healthcare” and what is considered public health, in order to improve health outcomes and curb rising costs, according to a new report from The Health Care Transformation Task Force and The Public Health Leadership Forum.

With the growing worldwide burden of chronic obstructive pulmonary disease (COPD), researchers in Australia recently reviewed literature looking for the best models to predict this disease, in an effort to identify new preventive strategies. Out of thousands of articles, the common denominator boiled down to one thing: smoking.

As Puerto Rico begins to update mortality statistics from 2017 that strengthen prior reports that the death toll from Hurricane Maria was much higher than first reported, a recent article by the Commonwealth Fund says there are 3 factors that worsened the death toll in Puerto Rico after last year's hurricane: an inadequate response, a poorer health baseline, and inadequate funding.

Major medical groups as well as patient advocacy groups filed friend-of-the-court briefs Thursday in Texas v. Azar, the lawsuit that seeks to overturn the Affordable Care Act (ACA), warning about the damage that would occur to American healthcare if the ACA is reversed by the courts. In addition, legal experts who have previously disagreed with each other about legal and policy questions about the ACA united in another filing, saying the arguments of both "the plaintiff States and the United States on the severability of the insurance mandate from the other provisions of the ACA are inconsistent with settled law."

CMS said it will not update its overall hospital quality star ratings on Hospital Compare as it planned to in July, and will instead seek feedback on planned changes from an expert panel and other stakeholders. Two industry groups, the American Hospital Association and America’s Essential Hospitals, both welcomed the move.

HHS Secretary Alex Azar appeared before a Senate committee to talk about the president's plan to lower drug prices, with legislators peppering him with questions about when prices would start to fall for US patients, which possible actions do or don’t need Congressional authority, transparency issues, and other points. Some senators also asked about the Department of Justice decision last week to not defend the Affordable Care Act in a Texas lawsuit.



Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo